News

Anticipating OneMain Holdings' Earnings Report: What Investors Should Know

Anticipating OneMain Holdings' Earnings Report: What Investors Should Know

What to Expect From OneMain Holdings' Upcoming Earnings

OneMain Holdings (NYSE: OMF) is set to announce its quarterly earnings report soon. Investors are looking forward to the company's performance indicators and whether it will exceed analysts' predictions. As anticipation builds, here's a deep dive into what to expect from OneMain Holdings in this earnings season.

Analyst Projections for Earnings

Experts predict that OneMain Holdings will post an earnings per share (EPS) of $1.59. Given last quarter's outcome, which was higher than expected, there are whispers of optimism among financial analysts about potential positive surprises coming up.

Investors Anticipate Strong Guidance

In addition to the earnings figure, investors are particularly interested in future guidance. They are hoping that OneMain will provide an outlook that indicates robust growth, thereby generating confidence among shareholders.

Reviewing Past Performance

Reflecting on the previous quarter, OneMain Holdings outperformed expectations, recording an EPS of $1.45 – a substantial $0.22 higher than what analysts had forecasted. However, despite the solid earnings, the stock experienced a marginal drop of 0.0% the following day.

Quarterly Performance Summary

Here’s a brief snapshot of OneMain Holdings' performance over the last several quarters:

Quarterly Earnings Summary:

QuarterQ2 2025Q1 2025Q4 2024Q3 2024
EPS Estimate1.231.571.151.14
EPS Actual1.451.721.161.26
Price Change %1.00-3.00-3.00-4.00

Current Stock Performance Insights

As of late October, OneMain Holdings shares were priced at $56.02, reflecting a 14.4% increase over the past year. This upward momentum appears to reassure long-term investors as they prepare for the next earnings release.

Market Sentiment Towards OneMain Holdings

Understanding market sentiment is critical for gauging OneMain Holdings’ future performance. Currently, the consensus among analysts is neutral, with a one-year price target averaging around $60.0, suggesting a potential upside of approximately 7.1% for investors.

Competitive Analysis of Share Performance

In the broader context of the industry, it’s useful to compare OneMain Holdings with its peers, such as Figure Technology and Enova International. These companies have been performing differently, presenting distinct growth trajectories.

  • Figure Technology has an average one-year price target of $46.25, indicating a downside risk of 17.44%.
  • Dave’s average target price sits at $284.83, reflecting an impressive potential upside of 408.44%.
  • Enova International’s analysts project a one-year target of $146.5, signifying a 161.51% upside potential.

Peer Performance Metrics

A comprehensive analysis reveals varying performance metrics among OneMain Holdings' competitors. Here’s how they stack up:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
FirstCash HoldingsBuy-0.05%$412.82M2.85%
Figure TechnologyOutperform52.91%$88.53M7.92%
DaveOutperform64.46%$114.47M4.34%
Enova InternationalBuy5.06%$373.75M6.39%

Key Takeaways from Competitive Analysis

OneMain Holdings stands out in the industry with a commendable revenue growth of 64.46%, which surpasses many of its competitors. However, it struggles with profitability metrics like return on equity, where it falls short compared to others.

OneMain Holdings: Understanding the Business Model

OneMain Holdings Inc is primarily a consumer finance company, offering various loan products through both physical branches and online platforms. This provides potential borrowers with personal loan options, credit cards, and financial wellness programs aimed at helping them navigate their financial journeys.

Financial Health Indicators for OneMain Holdings

Market Capitalization: Currently, OneMain Holdings faces challenges in size compared to industry benchmarks, which can impact its growth perceptions and operational capabilities.

Revenue Growth: The company's revenue has grown by 10.02% over the last quarter, highlighting a gradual increase in its earnings.

Net Margin: OneMain Holdings has a net margin of 13.7%, indicating some challenges in cost management and overall profitability.

Return on Equity (ROE): With an ROE of 5.06%, OneMain Holdings must find pathways to better utilize equity and improve return generation.

Return on Assets (ROA): The company’s ROA is below industry standards, reflecting the need for more efficient asset management practices.

Debt Management: OneMain Holdings has a debt-to-equity ratio of 6.63, highlighting concerns around its debt management strategies.

Frequently Asked Questions

What is OneMain Holdings' expected EPS for the upcoming earnings report?

Analysts expect OneMain Holdings to report an EPS of $1.59.

How did OneMain Holdings perform last quarter?

Last quarter, OneMain reported an EPS of $1.45, beating estimates by $0.22.

What is the current stock price of OneMain Holdings?

The current stock price of OneMain Holdings is around $56.02.

What is the market sentiment regarding OneMain Holdings?

The consensus rating among analysts is currently neutral, with a price target suggesting a 7.1% upside.

How does OneMain Holdings compare to its peers?

OneMain Holdings demonstrates strong revenue growth compared to its peers but struggles with profitability metrics like return on equity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocky Shore Gold Completes Initial Private Placement Tranche

Updated Category News Views 118

Rocky Shore Gold Completes Initial Private Placement Tranche Rocky Shore Gold Ltd. (CSE: RSG) has successfully announced the completion of the first tranche of its non-brokered private placement, raising significant funds to support its ongoing projects. The financing initiative, which was previously publicized, demonstrates the company's commitment to advancing its...

Continue Reading
Monthly Dividend Announcement from Ellington Credit Company

Updated Category News Views 185

Ellington Credit Company Declares Monthly Dividend Ellington Credit Company (NYSE: EARN) has made an exciting announcement regarding its financial commitment to its shareholders. The company's Board of Trustees has declared a monthly common dividend, establishing an amount of $0.08 per share. This dividend will be payable shortly, offering a tangible return to those...

Continue Reading
Halide Alagoz Sells Over $1.5 Million in Ralph Lauren Shares

Updated Category News Views 128

Halide Alagoz Completes Significant Stock Sale Recent reports indicate that Halide Alagoz, the Chief Product Officer at Ralph Lauren, executed a substantial insider sale according to official filings. Details of the Insider Transaction According to regulatory disclosures, Alagoz sold 5,282 shares of Ralph Lauren, resulting in a total transaction value of approximately...

Continue Reading
Midland States Bancorp, Inc. Declares Quarterly Dividends

Updated Category News Views 86

Midland States Bancorp, Inc. Declares Quarterly Cash Dividend Midland States Bancorp, Inc. (NASDAQ: MSBI) recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend is significant as it highlights the company’s commitment to delivering value to its shareholders. The payment will be available to shareholders of record on a...

Continue Reading
Standex International Sees Price Target Increase Amid Growth

Updated Category News Views 55

Standex International's Price Target Raised by DA Davidson Recently, Standex International (NYSE: SXI) experienced a notable increase in its price target, now set at $222.00, from analysts at DA Davidson. This update follows the company's fiscal year 2025 earnings report, coinciding with their performance in the third quarter of the calendar year. The previous price...

Continue Reading